Prosight Management
Latest statistics and disclosures from Prosight Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Galapagos Nv-, JANX, NKTR, BSX, STTK, and represent 46.83% of Prosight Management's stock portfolio.
- Added to shares of these 10 stocks: INSM (+$40M), BSX (+$20M), IRTC (+$19M), Galapagos Nv- (+$15M), MLYS (+$12M), SNDX (+$9.4M), ALNY (+$6.6M), STTK (+$6.6M), OPCH (+$5.7M), NKTR (+$5.2M).
- Started 5 new stock positions in PFE, EFOR, INSM, MLYS, OPCH.
- Reduced shares in these 10 stocks: PRCT (-$38M), MGTX (-$34M), WGS (-$30M), KURA (-$15M), CON (-$11M), TERN (-$11M), PHR (-$9.2M), ALKS (-$6.2M), SDGR (-$5.8M), OKUR (-$5.4M).
- Sold out of its positions in ACET, CON, IMVT, OMER, PVLA, PHR, RGNX, SDGR, TERN, TMDX. TBI, UPB, VKTX, NVCR, ROIV.
- Prosight Management was a net seller of stock by $-30M.
- Prosight Management has $580M in assets under management (AUM), dropping by -4.83%.
- Central Index Key (CIK): 0001617201
Tip: Access up to 7 years of quarterly data
Positions held by Prosight Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Prosight Management
Prosight Management holds 36 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lakefront Biotherapeutics Nv Spon Adr | 10.6 | $61M | +31% | 2.0M | 29.98 |
|
| Janux Therapeutics (JANX) | 10.1 | $58M | +7% | 3.8M | 15.36 |
|
| Nektar Therapeutics Com New (NKTR) | 9.7 | $57M | +10% | 810k | 69.81 |
|
| Boston Scientific Corporation (BSX) | 9.3 | $54M | +59% | 1.3M | 42.68 |
|
| Shattuck Labs (STTK) | 7.1 | $41M | +19% | 6.0M | 6.94 |
|
| Insmed Com Par $.01 (INSM) | 6.9 | $40M | NEW | 376k | 106.62 |
|
| Alnylam Pharmaceuticals (ALNY) | 5.1 | $30M | +29% | 98k | 301.03 |
|
| Syndax Pharmaceuticals (SNDX) | 4.5 | $26M | +55% | 1.2M | 21.86 |
|
| Kura Oncology (KURA) | 3.8 | $22M | -39% | 2.0M | 10.97 |
|
| Alkermes SHS (ALKS) | 3.6 | $21M | -23% | 394k | 52.40 |
|
| Irhythm Technologies (IRTC) | 3.4 | $20M | +1555% | 166k | 118.95 |
|
| Veeva Sys Cl A Com (VEEV) | 3.2 | $19M | +22% | 106k | 177.47 |
|
| Zymeworks Del (ZYME) | 3.0 | $18M | +25% | 674k | 26.14 |
|
| Abivax Sa Sponsored Ads (ABVX) | 2.5 | $14M | +2% | 107k | 133.26 |
|
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $14M | +7% | 375k | 37.42 |
|
| Mineralys Therapeutics (MLYS) | 2.1 | $12M | NEW | 450k | 26.98 |
|
| Adc Therapeutics Sa SHS (ADCT) | 1.4 | $8.4M | -5% | 7.8M | 1.07 |
|
| ICU Medical, Incorporated (ICUI) | 1.3 | $7.5M | +85% | 51k | 146.60 |
|
| Intuitive Surgical Com New (ISRG) | 1.2 | $6.8M | +325% | 17k | 397.68 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.1 | $6.1M | -6% | 650k | 9.38 |
|
| Procept Biorobotics Corp (PRCT) | 1.0 | $6.1M | -86% | 268k | 22.58 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 1.0 | $5.9M | -83% | 86k | 68.65 |
|
| Option Care Health Com New (OPCH) | 1.0 | $5.7M | NEW | 271k | 20.97 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.8 | $4.5M | -54% | 979k | 4.56 |
|
| Emergent BioSolutions (EBS) | 0.7 | $3.9M | -28% | 460k | 8.38 |
|
| Pfizer (PFE) | 0.6 | $3.3M | NEW | 135k | 24.08 |
|
| Orthopediatrics Corp. (KIDS) | 0.5 | $3.0M | -47% | 158k | 19.13 |
|
| Rocket Pharmaceuticals (RCKT) | 0.4 | $2.4M | +2% | 700k | 3.42 |
|
| An2 Therapeutics (ANTX) | 0.4 | $2.3M | -7% | 475k | 4.84 |
|
| Pliant Therapeutics (PLRX) | 0.3 | $1.6M | -17% | 1.4M | 1.14 |
|
| Tectonic Therapeutic (TECX) | 0.2 | $1.4M | -50% | 40k | 34.38 |
|
| Meiragtx Holdings (MGTX) | 0.2 | $1.2M | -96% | 90k | 13.51 |
|
| On Assignment (EFOR) | 0.2 | $1.2M | NEW | 68k | 17.87 |
|
| Rein Therapeutics Com New (RNTX) | 0.2 | $1.1M | +167% | 1.1M | 1.04 |
|
| Coya Therapeutics Common Stock (COYA) | 0.2 | $995k | -59% | 170k | 5.85 |
|
| Immuneering Corp Class A Com (IMRX) | 0.0 | $184k | -70% | 37k | 4.99 |
|
Past Filings by Prosight Management
SEC 13F filings are viewable for Prosight Management going back to 2017
- Prosight Management 2026 Q2 filed Aug. 14, 2026
- Prosight Management 2026 Q1 filed May 15, 2026
- Prosight Management 2025 Q4 filed Feb. 13, 2026
- Prosight Management 2025 Q3 filed Nov. 14, 2025
- Prosight Management 2025 Q2 filed Aug. 14, 2025
- Prosight Management 2025 Q1 filed May 15, 2025
- Prosight Management 2024 Q4 filed Feb. 14, 2025
- Prosight Management 2024 Q3 filed Nov. 14, 2024
- Prosight Management 2024 Q2 filed Aug. 14, 2024
- Prosight Management 2024 Q1 filed May 15, 2024
- Prosight Management 2023 Q3 filed Nov. 14, 2023
- Prosight Management 2023 Q2 filed Aug. 14, 2023
- Prosight Management 2023 Q2 restated filed Aug. 14, 2023
- Prosight Management 2023 Q1 filed May 12, 2023
- Prosight Management 2022 Q4 filed Feb. 14, 2023
- Prosight Management 2022 Q3 filed Nov. 14, 2022